Ratings
0
Nobody has rated this yet. Be the first!
Works
3
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%
Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping
